Immunology Research 2018
The EuroSciCon takes pleasure of announcing 22nd Edition Of International Conference On Immunology And Evolution Of Infectious Diseases from May 10-11, 2018 in Frankfurt, Germany. The theme of this year’s meeting is “Advanced therapies for deadly diseases" which provides an international platform for discussion of present and future summons in Advancements of immunology in curing the deadly infectious diseases, expertise meeting and review of research. World-leading Immunologists, Microbiologists, Biochemists, Scientists, Doctors and Doctorates will present cutting-edge and practical immunological techniques and methods with accepted evidence and will introduce new and emerging research.
Immunology Research 2018 is the perfect platform for the interaction among specialists, directors, professors, medical, surgical, miscellaneous faculties, experts, scientists, reputed research institutes, universities and medical schools and mainly accelerating the scientific discoveries in the field of Immunology and Infectious Diseases around the world
Frankfurt the most international city in Germany, the largest financial centre on the continent, the historical city of coronations, the city of Goethe and the Frankfurt School. In brief, it is the smallest metropolitan city in the world, where it has a lot to discover at close hand. Whether this glance at the city’s home page is the start of a longer, maybe even permanent, stay on the banks of the Main, or as a business visitor, with qualified amount of time available. You will find that city has exciting offers for extensive tours, cultural enjoyment and interesting shopping trips waiting for you.
Almost one among three people in Frankfurt does not hold a German passport. No matter from which place the visitor come from, they will always meet people in Frankfurt who speak their native language and a restaurant that serves their favorite food. The open and hospitable atmosphere in Frankfurt stems from its centuries-old role as a trading center. This democratic and liberal tradition of the Frankfurt city is one reason for the fact that people from very diverse cultures have lived here in peace with one another. All of these contribute in making the city shine differently from each and every angle, same as a jewel shines differently when you look at it from different sides.
Global Immunology Market to Reach $74.2 Billion By 2022
The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing. Market access presents a significant hurdle for immunotherapeutic procedures, as many are high cost and do not deliver the measurements required for traditional cost-effectiveness assessments. Despite these restraining factors, The Global Immunology Market is expected to experience continued growth, from $61.5 Billion in 2015 to $74.2 Billion in 2022, at 2.71% CAGR.
Immune-mediated deadly infectious diseases are a very common set of chronic disorders that affect 5–7% of world populations. Although they are often disparate in terms of their symptoms and key patient demographics, they are pathophysiological linked, being characterized by disregulation of immune pathways and an inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a highly generalized class of systemic small-molecule-based agents, are used in the first-line treatment of these diseases. These are supplemented in many cases by shorter-term glucocorticoid therapy, another class of highly generalized systemic agents.
However, these therapies often fail to elicit an adequate response; a large second-line therapy has emerged in markets, beginning with the approval of Remicade and Enbrel in 1998. This segment largely consists of premium systemic monoclonal Antibodies that are highly commercial and successful with their widespread usage and high cost. Though the patents for many of these mAbs are being expired during the forecast period, the market is expected to experience continued growth.
Though the patents for these mAbs are being expired during the forecast period, the market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.
- What factors are driving the market growth?
- How can the factors limiting growth are overcome?
- Very large pharmaceutical pipeline for immunology, consisting of 1,838 active products is being developed. However, the commercial performance of the products in the late-stage pipeline is expected to be moderate.
- What gaps in the market are being addressed by the most promising of these late-stage pipeline products?
- Several key commercially successful products, including Humira (adalimumab) and Remicade, are due to lose patent protection in the forecast period.
- How will this affect their revenues in this period?
- The key players in the market, all of which are among the top 20 pharmaceutical companies, are expected to maintain their market lead throughout the forecast period.
- What is driving this continued market dominance?
- Who will the new market players be?
Reasons to buy:
This report will allow you to
- Apprehend the present clinical and industrial landscape by considering disease pathogenesis and diagnostic treatment options available at each stage of Infection
- Envisage the composition of immunology market across every indication, in terms of dominant molecule targets, highlighting the key commercial assets and players
- Analyze the pipeline of immunology and stratify its developmental stage, molecular target along with molecule type and with its granular breakdown across key indications
- Acknowledge the growth of patient epidemiology and market revenues for the immunology globally and across the key players and product types
- Laminate the market in terms of the split between generic and premium products and assess the role of product types in treating varied immunological disorders
- Identify industrial opportunities in immunology by analyzing trends in licensing and co-development deals
Immunology and Infectious Diseases Info
University of Oxford | Swiss Federal Institute of Technology | University of Cambridge | King’s College London | University of Edinburgh | Swiss Federal Institute of Technology Lausanne | University of Bristol | University College London | Maastricht University | Imperial College London | University of St. Andrews | The University of Manchester | Queen Mary University of London | University of Liverpool | Trinity College Dublin | University of Birmingham | University of Southampton | University of Copenhagen | Newcastle University | University of Glasgow | University of Geneva | University of Zurich | Queen’s University Belfast | University of Groningen | Cardiff University | Technical University of Munich | University College Dublin | University of Warwick | University of Nottingham | University of York
Osaka University | University of Tokyo | National University of Singapore | Kyoto University | Mahidol University | Tel Aviv University | University of Hong Kong | Keio University | Hebrew University of Jerusalem | Seoul National University | National Taiwan University | Sun Yat-sen University | Fudan University | Zhejiang University | Peking University | Hokkaido University | Tehran University of Medical Sciences | Tohoku University | Shanghai Jiao Tong University | Yonsei University | Korea University | Shandong University | Sungkyunkwan University | University of Ulsan | Chang Gung University | Capital Medical University | National Yang-Ming University
University of Cape Town | University of Witwatersrand | University of Kwa Zulu Natal | Makerere University | Stellenbosch University | Cairo University | University of Pretoria | University of Malawi | Alexandria University | Mansoura University | Ain Shams University | International University of Africa | University of the Free State | University of Port Elizabeth | Nelson Mandela Metropolitan University | Rhodes University | North West University | University of Ghana | University of Johannesburg | University of Annaba | Université de Cocody | Al-Azhar University | St. Paul's Hospital Millennium Medical College | University of Health and Allied Sciences | University of Nairobi Medical School | University of Nigeria | University of Somalia | University of the Free State | International University of Africa | Hubert Kairuki Memorial University | Medical School of Tunis | National University of Science and Technology | University of Zimbabwe School of Medicine | University of Zambia School of Medicine
Albanian Society of Allergology and Clinical Immunology | Association for Cancer Immunotherapy | Austrian Society for Allergology and Immunology | Belgian Society for Allergy and Clinical Immunology | British Society of Allergy and Clinical Immunology | Bulgarian Society for Immunology | Commonwealth of Independent States Society of Allergology and Clinical Immunology | Czech Society of Allergology and Clinical Immunology | Danish Asthma and Allergy Association | German Society for Immunology | Estonian Society for Immunology and Allergology | European Academy of Allergy & Clinical Immunology | European Society of Clinical Microbiology and Infectious Diseases | European Federation for Immunogenetics | European Society for Paediatric Infectious Diseases | European Federation of Immunological Societies | European Macrophage and Dendritic Cell Society | European Society for Immunodeficiency | French Society for Immunology | French Society of Allergy and Clinical Immunology | German Society of Immunology | Hellenic Society of Immunology | Hungarian Society for Immunology | Icelandic Society of Allergy and Immunology | Immunology of Diabetes Society | Italian Society of Allergy, Asthma and Clinical Immunology | Kosovo Allergy Asthma and Immunology Association | Lithuanian Society for Immunology | Portuguese Society of Allergology and Clinical Immunology | Romanian Society for Immunology | Scandinavian Society for Immunology | Section of Clinical Immunology and Allergy of the Royal Society of Medicine | Spanish Society for Immunology | Ukrainian Society of Immunology and Allergy | World Immuno Pathology Organization
Academy of Clinical Laboratory Physicians and Scientists | Alabama Society of Allergy, Asthma, and Immunology | Algerian Society of Allergy and Clinical Immunology | American Academy of Allergy, Asthma and Immunology | American Association of Immunologists | American Association of Veterinary Immunologists | American Society for Histocompatibility and Immunogenetics | American Uveitis Society | Americas Committee for Treatment and Research in Multiple Sclerosis | Argentine Association of Allergy and Immunology | Association of Medical Laboratory Immunologists | Brazilian Association of Allergy and Immunology | Canadian Society for Immunology | Clinical Immunology Chapter of the Sociedad Mexicana de Inmunología | Clinical Immunology Society | Crohn’s and Colitis Foundation of America | Federation of Clinical Immunology Societies | Georgian Association of Allergology and Clinical Immunology | Immune Tolerance Network | International Complement Society | International Cytokine and Interferon Society| International Society for Interferon and Cytokine Research | International Society for Neuroimmunology | International Society of Developmental and Comparative Immunology | International Union of Immunological Societies | Lupus Foundation of America | National Institute of Allergy and Infectious Diseases | Pan American Group for Immunodeficiency | Portuguese Society of Allergology and Clinical Immunology | Psychoneuroimmunology Research Society | Society for Immunotherapy of Cancer | Society for Investigative Dermatology | Society for Mucosal Immunology | Society of Innate Immunity | The Antibody Society | World Allergy Organization | Uveitis Association of Mexico
Allergy & Immunology Society of Sri Lanka | Allergy and Clinical Immunology Society | Allergy, Asthma and Immunology Society of Thailand |Allergy, Asthma and Immunology Society of Thailand | Asthma Association Bangladesh | Australasian Society for Immunology | Australasian Society of Clinical Immunology and Allergy | Australasian Society of Clinical Immunology and Allergy | Bangladesh Society of Allergy and Immunology | Chinese Society of Allergology | Hong Kong Allergy Association | Indian Academy of Allergy | Indian College of Allergy, Asthma and Applied Immunology | Indian Immunology Society | Indonesian Society of Allergy and Immunology | Japanese Society for Immunology | Korean Academy of Asthma, Allergy and Clinical Immunology | Korean Association of Immunologists | Lebanese Society of Allergy and Immunology | Malaysian Society of Allergy and Immunology | Mongolian Society of Allergology | Philippine Society of Allergy, Asthma and Immunology | Taiwan Academy of Pediatric Allergy Asthma Immunology | Vietnam Association of Allergy, Asthma and Clinical Immunology
Allergy Society of Kenya | Allergy Society of South Africa | Armenian Association of Immunology and Allergy | Azerbaijan Society for Asthma, Allergy and Clinical Immunology | Belarus Association of Allergology & Clinical Immunology | Egyptian Society of Allergy and Clinical Immunology | Egyptian Society of Pediatric Allergy and Immunology | Federation of African Immunological Societies | Georgian Association of Allergology and Clinical Immunology | Moroccan Society of Allergology and Clinical Immunology | Nigerian Society for Immunology | Russian Association of Allergology and Clinical Immunology | South Africa Allergy Society | Tanzania Immunology Society | Tunisian Society of Immunology | Tunisian Society of Respiratory Diseases and Allergology | Turkish National Society of Allergy and Clinical Immunology | Ukrainian Allergists Association | Ukrainian Society of Specialists for Immunology, Allergology and Immunorehabilitation | Zimbabwe Allergy Society | Zimbabwe Society of Immunology
AFFiRiS | AOP Orphan Diseases | Apeiron Biologics | Aposcience | Arsanis Biosciences | BIA Separations | Biomay | Croma-Pharma | EverCyte | EXPUTEC | f-star | Haplogen | Hookipa Biotech | Janssen Pharmaceuticals | Lexogen | med Photon | Nabriva Therapeutics | Norgine | Octapharma | Pfizer | Polymun Scientific | Sandoz | Savira Pharmaceuticals | s-TARget Therapeutics | TAmiRNA | Teleflex Medical | Themis Bioscience | Thio Matrix | TUBE Pharmaceuticals | Valneva | Vela Laboratories | Vienna Lab Diagnostics | Vira Therapeutics | Biocrates
Bristol Myers Squibb | Shire | Abbott | Abbott Laboratories | Abbvie | Adheren | Advanced Immune Therapeutics | Allergan | Amgen | Amnis Corp. | Amplimmune | Azano Biotech | BioFront Technologies | Biogen | Biogen Idec | Bristol Myers Squibb | Celgene | Celgine Corporation | Eli Lilly & Co. | Gilead Sciences | Johnson & Johnson | Lycera | Merck & Co | Mylan | Pfizer | Prime Therapeutics | Selecta Biosciences | Valeant | Vitae Pharmaceuticals, Inc.